Canadian clinical-stage biotech Zymeworks (Nasdaq: ZYME) today announced that the National Medical Products Administration ...

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has published updated Final Draft Guidance recommending Forxiga (dapagliflozin) as an option to treat chronic ...

Japanese drugmaker Sumitomo Pharma (TYO: 4506) and Denmark’s Novo Nordisk (NOV: N) have entered into a co-promotion agreement ...

Japanese drugmaker Astellas Pharma (TYO: 4503) today announced an exclusive license agreement with China’s Evopoint ...

A typical advertisement for a prescription drug airs on television. The visuals are lively and upbeat; the people are smiling ...

Industry stakeholders have urged the European Medicines Agency to sharpen its guidance on decentralized clinical trials, ...

Philadelphia-based biotech Vivodyne has raised $40 million in series A funding to advance its fully robotic, AI-powered ...

Swiss pharma giant Roche (ROG: SIX) today announced new, 96-week data for fenebrutinib demonstrating that patients with ...

Shares in US biotech Intellia Therapeutics (Nasdaq: NTLA) slid by a quarter on Thursday following a safety update from its ...

US biotech Regeneron and French drugmaker Sanofi are reviewing next steps for their experimental COPD therapy itepekimab ...

Vima Therapeutics, a Cambridge, USA-based clinical-stage biotechnology company focused on oral therapies for movement ...

Swiss eye care specialist Alcon (SIX/NYSE: ALC) yesterday revealed the US Food and Drug Administration (FDA) has approved ...